CFDE Data Portal | Search LYPLAL1

	Label	Description
	LYPLAL1 associations Collection (Entity type)	Associations for LYPLAL1_associations
	LYPLAL1 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	LYPLAL1-AS1 associations Collection (Entity type)	Associations for LYPLAL1-AS1_associations
	LYPLAL1-AS1 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	LYPLAL1 Gene (Entity type)	ENSG00000143353 - lysophospholipase like 1
	LYPLAL1-DT Gene (Entity type)	ENSG00000228063 - LYPLAL1 divergent transcript
	GSE114492 GSE153671 KMT2D inhibition 6 v 8 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE138789 metformin 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE144443 0 V 6 NICOTINAMIDE MOUSE UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE146358 dopamine 3 v 7 human dn Gene Set (Entity type)	A Gene Set from LINCS

LYPLAL1 associations

Associations for LYPLAL1_associations

LYPLAL1 associations.tsv

A file from IDG as part of the Harmonizome project

LYPLAL1-AS1 associations

Associations for LYPLAL1-AS1_associations

LYPLAL1-AS1 associations.tsv

A file from IDG as part of the Harmonizome project

LYPLAL1

ENSG00000143353 - lysophospholipase like 1

LYPLAL1-DT

ENSG00000228063 - LYPLAL1 divergent transcript

GSE114492 GSE153671 KMT2D inhibition 6 v 8 human dn

A Gene Set from LINCS

GSE138789 metformin 0 v 1 human up

A Gene Set from LINCS

GSE144443 0 V 6 NICOTINAMIDE MOUSE UP

A Gene Set from LINCS

GSE146358 dopamine 3 v 7 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.